Age, comorbidity, treatment decision and prognosis in lung cancer

Approximately 80-85% of lung cancer subtypes are of non-small cell (NSCLC), two-thirds of which are at advanced stages on diagnosis. An observational study was conducted to analyze the influence of age and comorbidity on choice of treatment and prognosis in advanced NSCLC.

Saved in:
Bibliographic Details
Published in:Age and ageing 2008-11, Vol.37 (6), p.715-718
Main Authors: Blanco, José Antonio Gullón, Toste, Isabel Suárez, Alvarez, Ramón Fernández, Cuadrado, Gemma Rubinos, Gonzalvez, Agustín Medina, Martín, Isidro Jesús González
Format: Article
Language:English
Subjects:
Adult
Age
Age Factors
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung - diagnosis
Carcinoma, Non-Small-Cell Lung - drug therapy
Comorbidity
Decision making
Drug Therapy
Elderly people
Female
Geriatric Assessment
Geriatrics
Humans
Logistic Models
Lung cancer
Lung Neoplasms - diagnosis
Lung Neoplasms - drug therapy
Male
Medical prognosis
Medical treatment
Middle Aged
Morbidity
Multivariate Analysis
Prognosis
Retrospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Approximately 80-85% of lung cancer subtypes are of non-small cell (NSCLC), two-thirds of which are at advanced stages on diagnosis. An observational study was conducted to analyze the influence of age and comorbidity on choice of treatment and prognosis in advanced NSCLC.
ISSN:0002-0729
1468-2834
DOI:10.1093/ageing/afn226